Lv4
590 积分 2023-02-05 加入
Early Cancer Detection Through Comprehensive Mapping of Dynamic Tumorigenesis
2小时前
待确认
Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
30天前
已完结
Combined JAK inhibition and PD-1 immunotherapy for non–small cell lung cancer patients
30天前
已完结
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
1个月前
已完结
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer
1个月前
已完结
Blocking PCSK9 enhances immune checkpoint therapy
2个月前
已完结
A gut microbial signature for combination immune checkpoint blockade across cancer types
3个月前
已完结
Association of Immune-Related Adverse Events With Efficacy of Atezolizumab in Patients With Non–Small Cell Lung Cancer
3个月前
已完结
Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study
3个月前
已完结
Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: A Phase II Multicenter Study
4个月前
已完结
皖公网安备34019202002308
